文献速递乳腺癌

已确定的乳腺癌生殖与生活方式危险因素与由预后70基因表达特征(MammaPrint®)定义的肿瘤亚型的关联研究

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®).
PubMed 文献 · Eur J Cancer · 2017-02-16

研究基于MINDACT试验中1555例荷兰乳腺癌患者,用问卷收集已确定的生殖与生活方式危险因素,采用 logistic 回归分析这些因素与MammaPrint® 70基因预后特征(低危或高危肿瘤)的关联。结果显示当前BMI、初潮年龄、首次生育年龄、绝经年龄、激素避孕药使用和激素替代治疗使用与MammaPrint®无关联;在经产妇中,较高产次与较低的高危肿瘤风险相关(OR 0.75,95%CI 0.59-0.95,P=0.018),较长母乳喂养持续时间与较高的高危肿瘤风险相关(OR 1.03,95%CI 1.01-1.05,P=0.005),风险估计在雌激素受体阳性疾病中相似,按绝经状态分层后关联在绝经后女性中仍存在。

要点

  • 在经产妇中,较高产次与较低的高危肿瘤风险相关(OR 0.75,95%CI 0.59-0.95,P=0.018)。
  • 在经产妇中,较长母乳喂养持续时间与较高的高危肿瘤风险相关(OR 1.03,95%CI 1.01-1.05,P=0.005)。
  • 当前BMI、初潮年龄、首次生育年龄、绝经年龄、激素避孕药使用和激素替代治疗使用与MammaPrint®无关联。

核心结论

  • 使用预后基因表达特征,有迹象表明特定生殖因素可能与超出激素受体状态的预后肿瘤亚型相关。

研究设计与样本

  • 研究纳入MINDACT试验中的1555例荷兰乳腺癌患者,使用标准化问卷获取已确定的乳腺癌危险因素信息,从试验数据库获取临床病理和基因组信息,采用逻辑回归分析生活方式危险因素与由70基因MammaPrint®特征定义的肿瘤预后亚型(低危或高危)之间的关联。

主要发现

  • 1555例乳腺癌患者中,910例为低危肿瘤,645例为高危肿瘤。
  • 当前BMI、初潮年龄、首次生育年龄、绝经年龄、激素避孕药使用和激素替代治疗使用与MammaPrint®无关联。
  • 在经产妇中,较高产次与较低的高危肿瘤风险相关(OR 0.75,95%CI 0.59-0.95,P=0.018),较长母乳喂养持续时间与较高的高危肿瘤风险相关(OR 1.03,95%CI 1.01-1.05,P=0.005);风险估计在雌激素受体阳性疾病中相似。
  • 按绝经状态分层后,上述关联在绝经后女性中仍存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reproductive and lifestyle factors influence both breast cancer risk and prognosis; this might be through breast cancer subtype. Subtypes defined by immunohistochemical hormone receptor markers and gene expression signatures are used to predict prognosis of breast cancer patients based on their tumour biology. We investigated the association between established breast cancer risk factors and the 70-gene prognostication signature in breast cancer patients. PATIENTS AND METHODS: Standardised questionnaires were used to obtain information on established risk factors of breast cancer from the Dutch patients of the MINDACT trial. Clinical-pathological and genomic information were obtained from the trial database. Logistic regression analyses were used to estimate the associations between lifestyle risk factors and tumour prognostic subtypes, measured by the 70-gene MammaPrint® signature (i.e. low-risk or high-risk tumours). RESULTS: Of the 1555 breast cancer patients included, 910 had low-risk and 645 had high-risk tumours. Current body mass index (BMI), age at menarche, age at first birth, age at menopause, hormonal contraceptive use and hormone replacement therapy use were not associated with MammaPrint®. In parous women, higher parity was associated with a lower risk (OR: 0.75, [95% confidence interval {CI}: 0.59-0.95] P = 0.018) and longer breastfeeding duration with a higher risk (OR: 1.03, [95% CI: 1.01-1.05] P = 0.005) of developing high-risk tumours; risk estimates were similar within oestrogen receptor-positive disease. After stratifying by menopausal status, the associations remained present in post-menopausal women. CONCLUSION: Using prognostic gene expression profiles, we have indications that specific reproductive factors may be associated with prognostic tumour subtypes beyond hormone receptor status.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Makama M, Drukker CA, Rutgers EJT, et al. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®). Eur J Cancer. 2017. PMID: 28214658. doi:10.1016/j.ejca.2016.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。